Hot on the heels of a $150 million fundraise, Atsena Therapeutics is back with early-stage data for the company’s eye disease ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

New research reveals a retinal light test may hold the key to detecting Parkinson's disease long before motor symptoms appear ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

A density gradient of basement membrane laminins modulates retinal pigment epithelium contractility levels by differential ...

BioMed X and Boehringer Ingelheim are expanding their joint XSeed Labs incubator in Ridgefield, Connecticut, with the launch ...

Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biotechnology company developing gene therapies for the treatment of ...

Background Coronary artery disease (CAD) is linked to an increased risk of mild cognitive impairment (MCI). Effective and ...

Researchers in South Korea claimed to have developed a drug with the ability to reverse retinal damage and restore vision. A ...

Kennesaw State University researchers Mahmut Karakaya and Ramazan Aygun recently earned a National Institutes of Health (NIH) ...